Author

Pengfei Xu

Observed name: Peng-Fei Xu

Institution: Yuntianhua Group (China)

Observed institutions: Sun Yat-sen University, Yunnan University, Universität Ulm, Harbin Institute of Technology, Chinese PLA General Hospital, Wuhan University, The Seventh Affiliated Hospital of Sun Yat-sen University, Yuntianhua Group (China), Zhongnan Hospital of Wuhan University, Peking University Shenzhen Hospital, First Affiliated Hospital of Anhui Medical University, Renmin Hospital of Wuhan University, Sun Yat-sen University Cancer Center, University Hospital Ulm

ORCID: 0000-0003-2793-9723

Observed ORCID: 0000-0003-2793-9723

OpenAlex ID: A5101573512

World’s first application of a self-deployable mechanism based on shape memory polymer composites in Mars explorations: ground-based validation and on-Mars qualification

2022 · Dou Zhang, Liwu Liu, et al. · Smart Materials and Structures · 47

PCBP2 maintains antiviral signaling homeostasis by regulating cGAS enzymatic activity via antagonizing its condensation

2022 · Haiyan Gu, Jing Yang, et al. · Nature Communications · 35

Ancient papyrus scroll-inspired self-deployable mechanism based on shape memory polymer composites for Mars explorations

2022 · Dou Zhang, Liwu Liu, et al. · Composite Structures · 31

Synthetic mRNA-based gene therapy for glioblastoma: TRAIL-mRNA synergistically enhances PTEN-mRNA-based therapy

2022 · Xiangjun Tang, Hao Peng, et al. · Molecular Therapy — Oncolytics · 25

O-GlcNAcylation attenuates ischemia-reperfusion-induced pulmonary epithelial cell ferroptosis via the Nrf2/G6PDH pathway

2025 · Liuqing Yang, Hexiao Tang, et al. · BMC Biology · 21

Whole exome sequencing reveals the genetic heterogeneity and evolutionary history of primary gliomas and matched recurrences

2022 · Peng-Fei Xu, Cong Li, et al. · Computational and Structural Biotechnology Journal · 17

Design and synthesis of fluorine aromatic scaffolds containing drugs approved by the US FDA from 2002 to 2022

2024 · Pengfei Xu, Lijun Zhu, et al. · Results in Chemistry · 13

[Corrigendum] HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma

2022 · Yangzhi Qi, Gang Deng, et al. · Oncology Reports · 6

m6A Topological Transition Coupled to Developmental Regulation of Gene Expression During Mammalian Tissue Development

2022 · Shanshan Li, Qing Yang, et al. · Frontiers in Cell and Developmental Biology · 6

Technical performance and quality assurance of the CyberKnife® S7™ system

2025 · Hanshun Gong, Shaojuan Wu, et al. · Radiation Medicine and Protection · 1

Vaccarin treats lactation insufficiency through the ALKBH5-SFRP2-Wnt/β-catenin signaling pathway

2025 · Qiuyun Xue, Hui Li, et al. · Journal of Ethnopharmacology · 1

Scalable Synthesis of p ‐Difluorobenzene, o ‐Difluorobenzene and 1, 2, 4‐Trifluorobenzene

2026 · Zilong Li, Zhiwei Meng, et al. · ChemistrySelect

AB047. Searching for factors relating to long-term survivors of glioblastoma

2024 · Depei Li, Pengfei Xu, et al. · Chinese Clinical Oncology

Spatial metabonomics in immuno-oncology

2024 · Delong Zhao, Pengfei Xu · Elsevier eBooks

Diisothiocyanate-Derived Mercapturic Acids Are a Promising Partner for Combination Therapies in Glioblastoma

2022 · Pengfei Xu, Mike-Andrew Westhoff, et al. · ACS Omega

Works count: 15

Citation count: 203

H-index: 7

I10-index: 7